A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation.

Abstract

OBJECTIVE The objectives of this study were to (a) identify the patterns of disulfiram (Antabuse) and tablet naltrexone (Revia) adoption over a 48-month period in a nationally representative sample of privately funded programs that deliver substance use disorder treatment; (b) examine predictors of sustainability, later adoption, discontinuation, and… (More)

Topics

Cite this paper

@article{Abraham2011ALE, title={A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation.}, author={A. J. Abraham and Hannah K. Knudsen and Paul Roman}, journal={Journal of studies on alcohol and drugs}, year={2011}, volume={72 4}, pages={669-77} }